The Therapeutic Aryl Hydrocarbon Receptor–Modulating Agent Tapinarof Regulates SEMA3A Expression in Human Keratinocytes through NRF2
Gaku Tsuji(Kyushu University), Takeshi Nakahara(Kyushu University)
Cited by 4
Related Papers
Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis
|Cell Death and Disease|2017|139
Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis
|Cell Death Discovery|2020|88
Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target
|International Journal of Molecular Sciences|2022|36
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma
|Cell Death Discovery|2023|15
NECTIN4‐targeted antibody–drug conjugate is a potential therapeutic option for extramammary Paget disease
|Experimental Dermatology|2024|7